Stuttgart
02.03.26 | 15:33
0,001 Euro
-94,85 % -0,013
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,000 | 0,014 | 22:52 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Change in number of shares and votes in Episurf Medical | 1 | Cision News | ||
| Mi | New US patent approval for Episurf Medical | 1 | Cision News | ||
| Di | The Board of Directors of Episurf has resolved on an issue of Class B shares, convertible debentures and warrants as part of the consideration for the acquisition of real estate assets | 2 | Cision News | ||
| 23.02. | Episurf Medical AB announces outcome of exercise of warrants of series TO14 B | 1 | Cision News | ||
| 23.02. | Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2026 | 1 | Cision News | ||
| 10.02. | Episurf Medical AB: Episurf Medical announces leadership changes effective from 11 February 2026 | 129 | GlobeNewswire (Europe) | Episurf Medical (Nasdaq: EPIS B) announces leadership changes effective from 11 February 2026. Jens Andersson, elected as a Board member of Episurf at the Extraordinary General Meeting on 10 February... ► Artikel lesen | |
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 10.02. | Episurf Medical AB: Press release from extraordinary general meeting in Episurf Medical AB (publ) | 162 | GlobeNewswire (Europe) | Episurf Medical AB (publ) today 10 February 2026 held an extraordinary general meeting in Stockholm.
Approval of the acquisition etc.
The extraordinary general meeting resolved, in accordance with... ► Artikel lesen | |
| 09.02. | The exercise period for warrants of series TO14 B in Episurf commences today | 1 | Cision News | ||
| 06.02. | Episurf Medical AB: Year-end Report 1 January - 31 December 2025 | 117 | GlobeNewswire (Europe) | Significant company transformation through the purchase of real estate and continued progress in the medical device business
"We have taken significant steps forward in 2025. For the fourth quarter... ► Artikel lesen | |
| 26.01. | Episurf Medical AB: Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo | 184 | GlobeNewswire (Europe) | Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 26 January 2026, entered into an agreement regarding the acquisition of a property portfolio consisting of residential... ► Artikel lesen | |
| 08.01. | Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change | 7 | Cision News | ||
| 08.01. | Notice of Extraordinary General Meeting of Episurf Medical AB (publ) | 1 | Cision News | ||
| 30.12.25 | Episurf Medical AB receives observation status | 275 | GlobeNewswire | Today, December 30, 2025, Episurf Medical AB (the "Company") issued a press release with information that the Company had entered into an agreement regarding the acquisition of all shares in Goldcup... ► Artikel lesen | |
| 30.12.25 | Episurf Medical AB: Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants | 206 | GlobeNewswire (Europe) | The Board of Directors of Episurf Medical AB (publ) (NASDAQ: EPIS B) ("Episurf" or the "Company") has today, 30 December 2025, entered into an agreement with Goldcup 38657 AB (under name change to Frusipe... ► Artikel lesen | |
| 18.11.25 | Update on Episurf Medical's MTP implant | 3 | Cision News | ||
| 02.11.25 | Board Member Resigns from the Board of Episurf Medical | 2 | Cision News | ||
| 24.10.25 | Episurf Medical AB: Interim Report 1 January - 30 September 2025 | 171 | GlobeNewswire (Europe) | Strong US growth in gross-order intake and customer base
Significantly improved financial results
Continued focus on regulatory pathway for MTP-implant
"This is my first CEO statement as CEO... ► Artikel lesen | |
| 17.10.25 | EPISURF MEDICAL AB: Scientific article on Episealer Knee with up to 10 years' follow-up published | 3 | Cision News | ||
| 12.10.25 | Board Member Resigns from the Board of Episurf Medical | 3 | Cision News | ||
| 30.09.25 | Change in number of shares and votes in Episurf Medical | 2 | Cision News |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 2,540 | +3,25 % | Imunon, Inc.: IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update | R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advanced... ► Artikel lesen | |
| ELECTROCORE | 6,400 | +4,06 % | electroCore, Inc.: electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8-$32.0 Million | Record revenue of approximately $31.8 - $32.0 million for full-year 2025 and approximately $9.0 - $9.2 million for the three months ended December 31, 2025 Revenue growth of approximately 26% over... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,370 | -2,41 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,78 | -1,05 % | Dax-Konzern liefert: Fresenius legt starkes Jahresergebnis vor und erhöht die Dividende | © Foto: Arne Dedert/dpaEin starkes Schlussquartal treibt Fresenius zu soliden Jahreszahlen und höherer Dividende, doch die Aktie reagiert mit Verlusten.Der Gesundheitskonzern Fresenius hat im Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,840 | +1,58 % | Fresenius Medical Care: Hohe Kursverluste trotz starker Quartalszahlen | Die UBS bleibt bei ihrer Verkaufsempfehlung für Fresenius Medical Care und warnt vor zu optimistischen Markterwartungen für die kommenden Jahre. Trotz eines starken Quartals sieht die Großbank weiterhin... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,800 | -5,43 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| GERRESHEIMER | 16,120 | +2,68 % | Gerresheimers Abschluss unter dem Röntgenblick der BaFin | Die BaFin verschärft den Blick auf die Rechnungslegung der Gerresheimer AG. Sie kündigt an, die am 18.09.2025 gestartete Anlassprüfung des offengelegten Konzernabschlusses und Konzernlageberichts 2023/2024... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,920 | +14,34 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,110 | -0,40 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| OTTOBOCK | 58,00 | +3,76 % | Ottobock greift nach der "Gedanken-Hand": 5 Mio. US-Dollar in Neuro-Implantate - nächster Gamechanger in der Prothetik? | Ottobock setzt beim nächsten Innovationssprung in der Prothetik auf eine klare Botschaft: Kapital plus Kontrolle. Im Rahmen einer Series-A-Finanzierung investiert der Human-Bionics-Marktführer 5 Mio.... ► Artikel lesen | |
| PROGYNY | 17,600 | -0,48 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| CLEARPOINT NEURO | 9,805 | -21,93 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen |
Das Unternehmen EPISURF MEDICAL AB kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,013 (-94,85 %) liegt der Kurs bei 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.